These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1325818)

  • 1. Inhibition of HIV infection of resting peripheral blood lymphocytes by nucleosides.
    Watson AJ; Wilburn LM
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1221-7. PubMed ID: 1325818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
    Gao WY; Shirasaka T; Johns DG; Broder S; Mitsuya H
    J Clin Invest; 1993 May; 91(5):2326-33. PubMed ID: 8387546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol.
    Heredia A; Davis C; Redfield R
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):246-55. PubMed ID: 11115955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
    Shirasaka T; Yarchoan R; O'Brien MC; Husson RN; Anderson BD; Kojima E; Shimada T; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):562-6. PubMed ID: 8380641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of anti-HIV nucleosides in microswine.
    Swagler AR; Qian MX; Gallo JM
    J Pharm Pharmacol; 1991 Dec; 43(12):823-6. PubMed ID: 1687578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the in vitro infectivity and cytopathic effect of human foamy virus by dideoxynucleosides.
    Santillana-Hayat M; Valla J; Canivet M; Peries J; Molina JM
    AIDS Res Hum Retroviruses; 1996 Oct; 12(15):1485-90. PubMed ID: 8893056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of drug-related genotypic changes in HIV-1 from serum using the selective polymerase chain reaction.
    Anderson BD; Shirasaka T; Kojima E; Yarchoan R; Mitsuya H
    Antiviral Res; 1994 Dec; 25(3-4):245-58. PubMed ID: 7710271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells.
    Lake-Bakaar G; Mazzoccoli V; Dickman K; Lyubsky S
    Dig Dis Sci; 2001 Sep; 46(9):1853-63. PubMed ID: 11575436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes.
    Mercure L; Brenner BJ; Phaneuf D; Tsoukas C; Wainberg MA
    Antimicrob Agents Chemother; 1994 May; 38(5):986-90. PubMed ID: 8067781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
    Gong YF; Srinivas RV; Fridland A
    Mol Pharmacol; 1993 Jul; 44(1):30-6. PubMed ID: 8341276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.
    Veal GJ; Wild MJ; Barry MG; Back DJ
    Br J Clin Pharmacol; 1994 Oct; 38(4):323-8. PubMed ID: 7833221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of N-butyl deoxynojirimycin in inhibiting HIV-1 infection and activity in combination with nucleoside analogs.
    Ratner L; Vander Heyden N
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):291-7. PubMed ID: 8390276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility of retroviruses to nucleoside analogues.
    Rosenblum LL; Patton G; Grigg AR; Frater AJ; Cain D; Erlwein O; Hill CL; Clarke JR; McClure MO
    Antivir Chem Chemother; 2001 Mar; 12(2):91-7. PubMed ID: 11527046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
    Chen CH; Vazquez-Padua M; Cheng YC
    Mol Pharmacol; 1991 May; 39(5):625-8. PubMed ID: 1851960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells.
    Dornsife RE; St Clair MH; Huang AT; Panella TJ; Koszalka GW; Burns CL; Averett DR
    Antimicrob Agents Chemother; 1991 Feb; 35(2):322-8. PubMed ID: 1708977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function.
    Lucia MB; Cauda R; Landay AL; Malorni W; Donelli G; Ortona L
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):893-901. PubMed ID: 7492436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
    Richman DD; Kornbluth RS; Carson DA
    J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitor.
    Winslow DL; Mayers D; Scarnati H; Lane J; Bincsik A; Otto MJ
    AIDS; 1994 Jun; 8(6):753-6. PubMed ID: 8086132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2',3'-dideoxynucleoside activities against replication of human immunodeficiency virus.
    Gao WY; Johns DG; Chokekuchai S; Mitsuya H
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8333-7. PubMed ID: 7667290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.